EP1215994B1 - Medizinisches implantat zur fühlung, datenspeicherung und zur telemetrie - Google Patents

Medizinisches implantat zur fühlung, datenspeicherung und zur telemetrie Download PDF

Info

Publication number
EP1215994B1
EP1215994B1 EP00961948A EP00961948A EP1215994B1 EP 1215994 B1 EP1215994 B1 EP 1215994B1 EP 00961948 A EP00961948 A EP 00961948A EP 00961948 A EP00961948 A EP 00961948A EP 1215994 B1 EP1215994 B1 EP 1215994B1
Authority
EP
European Patent Office
Prior art keywords
sensors
sensor
implant
actuator
data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP00961948A
Other languages
English (en)
French (fr)
Other versions
EP1215994A1 (de
Inventor
Marvin J. Slepian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endoluminal Therapeutics Inc
Original Assignee
Endoluminal Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endoluminal Therapeutics Inc filed Critical Endoluminal Therapeutics Inc
Priority to EP07000766A priority Critical patent/EP1847217A2/de
Publication of EP1215994A1 publication Critical patent/EP1215994A1/de
Application granted granted Critical
Publication of EP1215994B1 publication Critical patent/EP1215994B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031—Implanted circuitry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue

Definitions

  • This disclosure is generally in the area of implants which include sensors capable of detecting or interrogating physical, cellular, and other variables, including means for collecting, amplifying, storing and telemetering information as well as a feedback loop and means for modifying the implant after placement in a patient in response to measurements made using the sensors.
  • Medical implants have been used for many years in interventional radiology, gastroenterology, urology and cardiology and other fields of medicine and surgery. In general, these devices are static and not interactive, i.e., they are implanted for a particular purpose and no change occurs, save for bystander corrosion or biodegradation, over time or for removal in the event a problem develops.
  • conventional implants are fashioned from medical grade stainless steel, compatible polymers, e.g. Dacron TM or Teflon TM , or ceramics. More advanced implants have been developed using shape memory metals and polymers. Shape memory is the ability of a material to remember its original shape, either after mechanical deformation, or by cooling and heating. These materials have been proposed for various uses, including vascular implants, medical guidewires, orthodontic wires,etc.
  • a sensor for example, sensors for cardiac activity or sensors for monitoring blood flow.
  • the sensors measure flow, pressure and/or strain.
  • Most are not remotely “interrogatable”, which is understood to mean that data cannot be extracted remotely, after implantation in a body.
  • Some are remotely interactive, however.
  • batteries can be re-charged non-invasively.
  • Some sensors are interactive at the site of implantation, but not remotely. Most require some type of "hard-wiring" to either program the device or to extract data.
  • the '387 sensor generates an electromagnetic, ultrasonic and/or radio frequency signal indicative of the rate of blood flow in the associated vessel.
  • U.S. Patent No. 5,833,603 to Kovacs, et al. describes an implantable transponder including a sensor for temperature, strain, pressure, magnetism, acceleration, ionizing radiation, acoustic waves, or chemicals, where the sensor can be associated with an implanted prosthetic or graft. Data is transmitted to a remote reader.
  • a medical implant containing a magnetic field detector with a capacitative sensor detecting changes in the presence of a magnetic field, and means for generating a remotely-detectable signal, for use in determining an appropriate medical therapy.
  • U.S. Patent No. 5,928,248 to Acker describes a stent including a system which transmits non-ionizing fields between a transducer or transducers on the probe and external transducers, to aid in positioning of the stent.
  • None of these devices are responsive to the data which is collected by the sensors. None of these devices incorporates means of repeated or interval or programmed interrogation, via either intrinsic or extrinsic interrogative means. None of these devices incorporates within the device means for signal processing and interpretation. None of these devices includes means for raw or processed data storage. Non of these devices has incorporated intrinsic or proximate means for change, i.e. alteration of the local environment or local or distant therapy as a result of gathered information. Further, none of these devices has the ability to telemeter and interact with data transmission or communication means which exist as single or multiple e.g. nested, loops of information transfer. Therefore it is an object of the present invention to provide devices and systems incorporating such devices, for implantation in a patient wherein the implant includes means for collection, and/or processing and/or storage of data.
  • US-A-5544651 discloses a system comprising a sensor for measuring a predetermined physiological parameter of a patient, and generating a signal including a measured value of the physiological parameter.
  • a treatment component is operatively connected to a computer that compares the measured value with a predetermined threshold value, the treatment component being activated in the event of the measured value passing the threshold value.
  • US-A-5544651 The operative parts of the system of US-A-5544651 are stated to be implantable inside a patient, but when so configured they exist as discrete devices. US-A-5544651 does not describe any practical arrangements that genuinely render the system thereof suitable for implantation.
  • US-A-5833623 discloses a computer-based programmable device for interrogating an implanted pacemaker.
  • the programmable device receives historical data from the pacemaker, during a diagnostic session of limited duration e.g. in a physician's office.
  • WO-A-92/21307 discloses an ingestible device that is capable of signalling, to outside a patient's body, its position in the alimentary canal.
  • the ingestible device of WO-A-92/21307 also is operable, following transmission of an activation signal, generated outside the body, to dispense a medicaments or other substances. It is however disclosed in WO-A-92/21307 that when the device is configured to signal its position it does not function to dispense medicament, and vice-versa. Thus it is necessary for a patient to swallow one of the devices for the purpose of "mapping" the alimentary canal, before subsequently swallowing another of the devices for the purpose of medicament dosing.
  • US-A-5769893 discloses an implantable device for inducing growth of soft tissues of a patient.
  • a monitoring and control device may monitor and control the amount of growth.
  • US-A-5769893 cannot respond to the environment of the implanted device. On the contrary, human intervention is needed to initiate and terminate operation of the device, through the use of push buttons.
  • Implantable devices including sensors for data measurement, and/or data analyzers, and/or data storage means, and/or data telemetry/transmission means including means for communication at multiple levels or isolated or nested levels of information transfer have been developed. These devices may have incorporated means for modification of the implant or mounting a response, e.g. local or systemic drug delivery, in response to measurements made using the sensors. These are particularly useful in urology, hepatology or cardiology, where the implants contain one or more sensors responsive to variables which change over time, for example, pressure which is indicative of changes in fluid flow and diameter of the ureter, biliary duct or vessel in which the implant has been placed.
  • the implant contains a bioactive, prophylactic, diagnostic or pH modifying agent.
  • the implant is formed of a temperature or pH responsive material so that the agent is released when the temperature or pH is altered.
  • a remote data storage or manipulation system such as a watch-like device, small portable device, intra or extradermal implant, phone system devices (portable phones, answering services, beepers, office fax machines), portable computer, personal digital assistant (PDA, e.g., Palm Pilot TM systems), or to the internet (world wide web) or a computer accessible through devices that the physician or nurse can monitor or use to interact remotely with the implant.
  • a remote data storage or manipulation system such as a watch-like device, small portable device, intra or extradermal implant, phone system devices (portable phones, answering services, beepers, office fax machines), portable computer, personal digital assistant (PDA, e.g., Palm Pilot TM systems), or to the internet (world wide web) or a computer accessible through devices that the physician or nurse can monitor or use to interact remotely with the implant.
  • PDA personal digital assistant
  • implants may be of a wide variety of shapes and configurations. In general the shape will be dictated by the location of internal implantation as well as function. Implanted devices may be of many forms. For example, such devices might include various types of stents, such as endoluminal stents, stent-grafts, grafts (including by-pass grafts), rings, hooks, sutures, wires, and tissue conduits. Such devices may be implanted in locations such as arteries, veins, venous fistulas, bile ducts, the ureter, fallopian tubes, and artificial spaces created surgically.
  • stents such as endoluminal stents, stent-grafts, grafts (including by-pass grafts), rings, hooks, sutures, wires, and tissue conduits.
  • Such devices may be implanted in locations such as arteries, veins, venous fistulas, bile ducts, the ureter, fall
  • Implants as contemplated herein might be implanted by various methods including needle, trocar, percutaneous implantation, surgical implantation, and endoscope. Implants would preferably be made of materials which did not provoke an immune response, and which resisted fouling, if tissue ingrowth were not desired.
  • the function of the implant may be strictly to sense, to sense and store data, to sense, store and amplify or otherwise process data or to sense, store, process and transmit or otherwise communicate the information via electrical, electromagnetic, optical, radio, chemical, ultrasonic, thermal or other means.
  • the implant may have innate support, augmentative or therapeutic functions to directly modulate the contiguous implant zone tissue or alter function in the peri-zone or at a distance.
  • Diagnostic implants may be simple spheres, pellets, wafers, slivers, chips, or weaves, fabrics or stamp-like arrays of these or other shapes.
  • An example of simple support implants are tubes made of metal or plastic that is inserted into a body lumen, vessel or passage to keep the lumen open and prevent closure due to stricture or external compression. Implants are commonly used to keep open bile ducts for treatment of pancreatic cancer or cholangiocarcinoma, the oesophagus for strictures or cancer, the ureters to maintain drainage from the kidneys or blood vessels, i.e. coronary or peripheral arteries.
  • implants can also refer to prosthetics for repair or replacement of tissue, connective tissue or bone, where the device supports or seals an injury due to surgery, trauma or disease, or which is seeded with cells to repair or replace tissue or an injury thereto.
  • Implants are generally made of a biocompatible material, which may be biodegradable or more typically, non-biodegradable.
  • Exemplary materials include metals such as titanium, nitinol and surgical stainless steel, ceramics, and synthetic polymeric materials.
  • Non-biodegradable materials include polyethylene, TEFLON TM and pyrolytic carbon.
  • Preferred biodegradable polymers include polylactic acid, polyglycolic acid, polycaptolactone and copolymers thereof.
  • One or more sensors can be positioned in, on or as part of the implant. These can be used to measure temperature, mechanical forces such as stress and strain, pressure, and force; fluid flow properties such as flow rate and shear, electromagnetic fields, and chemical factors or variables, including pH, ion concentration, enzymes (presence of, activity of, or use of to measure other elements), and analyte concentrations or distributions. Sensors can also be used to monitor alterations in concentration or distribution of cells or tissues based on volume, or properties of the cells or tissue, such as stiffness, elasticity, surface adhesivity, and surface charge, changes in metabolic products, changes in antigenicity or cell surface expression, and the presence of foreign depositions including inorganic, organic and microbial materials.
  • Examples of applications of these sensors include measuring changes in weight by measuring changes in adipocyte cell volume and fat mass/lipid across a region such as a limb and measuring tissue fibrosis as changes in stiffness of a tendon, skin stiffness or muscle tension or ridigity.
  • Other applications relating to fouling of the implant over time include measurements relating to protein deposition or formation of a bacterial film on the biliary stent, increase in calcification of a urinary stent, and neointimal thickening of an arterial stent, resulting in an increase in thickness, mass and wall shear.
  • Sensors can be located on the surface, inside a hollow or porous wall of the implant, or inside a device in communication with the body tissue via a conduit to the implant (solid, hollow, or porous).
  • These sensors primarily include one or more of four classes of transducers: potentiometric, amperometric, optical, and physiochemical.
  • An amperometric sensor monitors currents generated when electrons are exchanged between a biological system and an electrode. Blood glucose sensors frequently are of this type.
  • Potentiometric sensors measure changes in potential between electrodes positioned apart from each other in an area over which a measurement is to be made, for example, as described by U.S. Patent No. 6,091,980 to Squire, et al.
  • the sensors may include means for transmitting a signal to monitoring means or directly to actuating means.
  • the means for transmitting a signal may be hard wired or transmitted via radio waves or magnetic or mechanical means.
  • a parameter indicative of the status of fluid flow is remotely monitored in a vessel, a natural graft, or a synthetic graft.
  • One or more transducers are provided either in a wall of a synthetic graft or adjacent to a vessel or natural graft to monitor the parameter.
  • a conformal array transducer or a tilted element is used to monitor fluid flow or velocity through the graft or vessel based on the effect of the fluid on ultrasonic waves produced by the transducers.
  • the conformal array transducer comprises a plurality of elements that curve around the graft or vessel and are excited with an input signal provided by an implantable electronics circuit, producing ultrasonic waves that propagate into the fluid flowing within the graft or vessel.
  • Transit time or Doppler measurements are made using an appropriate number of these transducer to determine either fluid flow or velocity.
  • Various implantable electronic circuits are provided that enable a selected transducer to be driven and to receive an ultrasonic signal or a pressure signal indicative of the status of fluid flow monitored by the transducer.
  • the implanted electronic circuit can be connected to an implanted radio frequency (RF) coil.
  • An external coil that is connected to a power supply and monitoring console is coupled to the implanted RF coil to convey power and receive data signals from the transducer that are indicative of the parameter being monitored.
  • U.S. Patent No. 5,833,603 describes implantable transponders utilizing temperature sensors, strain sensors, pressure sensors, magnetic sensors, acceleration sensors, ionizing radiation sensors, acoustic wave sensors, chemical sensors including direct chemical sensors and dye based chemical sensors, and photosensors including imagers and integrated spectrophotometers.
  • the transponder includes an energy coupler for wirelessly energizing the device with a remote energy source, and a control circuit for controlling and accessing the biosensor and for storing identifying data.
  • the energy coupler can be an inductive circuit for coupling electromagnetic energy, a photoelectric transducer for coupling optical energy, or a piezoelectric transducer for coupling ultrasonic energy.
  • the control circuit can be configured to delay, either randomly or by a fixed period of time, transmission of data indicative of the sensed parameter value to thereby prevent a data collision with an adjacent like device.
  • U.S. Patent No. 5,709,225 describes a magnetic field detector with a sensor whose capacitance changes in the presence of a magnetic field with a predefined strength, and a capacitance-controlled unit connected to the sensor.
  • the capacitance-controlled unit sends a measurement signal to a detection unit. If a measurement signal parameter affected by capacitance exhibits a specific change over a predefined period of time, a detection signal is generated by the detection unit to indicate the presence of a magnetic field.
  • the sensor's capacitance also changes when the sensor moves, and this is utilized for measuring activity in an activity measurement circuit connected to the capacitance-controlled unit and for generating an activity signal on the basis of the measurement signal.
  • U.S. Patent No. 5,865,972 describes integrated electrochemical microsensors for chemical analysis, allowing the determination of concentration or concentration profile of at least one chemical compound with small size or molecular weight, under organic, inorganic, neutral or ionic form in an aqueous environment.
  • the microsensor comprises an array of microelectrodes, assembled on a chip supported by an isolating substrate, and linked with at least one conductor protected by an insulating layer to a contact allowing the connection to a measuring apparatus.
  • U.S. Patent No. 5,898,004 discloses crystalline colloidal array sensors. The hydrogels are capable of shrinking and swelling in response to specific stimuli applied thereto.
  • U.S. Patent No. 5,883,310 describes a micromachined hot-wire shear stress sensor.
  • the micromachined hot-wire anemometer having fast response times and higher sensitivities than conventional hot-wire anemometers is provided by micromachining doped polysilicon wires carried on silicon supports cantilevered from a substrate including one or more insulating layers disposed between said substrate and supports.
  • the micromachined polysilicon hot-wire anemometer is fabricated using surface micromachining techniques.
  • a shear stress sensor is micromachined to define a thin diaphragm over a cavity defined in a substrate underlying the diaphragm.
  • the cavity is evacuated, sealed, and a thermistor disposed over the diaphragm.
  • the thermistor is thus thermally insulated from the substrate and provides a low profile shear stress sensor for measuring flow rates in boundary layers above a flow surface. See also U.S. Patent No. 5, 511,428 , 5,512,882 , 5,526,703 , 5,536,963 , 6,053,873 , 5,411,551 and EP 0 850 654 A1 .
  • the sensors can also include means for storage of data. Silicon wafer prepared using standard photolithographic or other manufacturing techniques can be included in the sensors for storage of data over time, which can be accessed routinely during the time the sensor is implanted, or downloaded after removal of the implant containing the sensor.
  • a number of devices can be used to receive and transmit signals from the sensors to the actuators. These may be radio transponders, light, or sound wave receivers and transmitters, or hard wired into the devices.
  • the ultrasonic sensor described in U.S. Patent No. 5,807,258 can be used to monitor the condition of a vascular graft.
  • One or more transducers are provided either in a wall of the implant or adjacent to the implant to monitor the parameter.
  • a conformal array transducer or a tilted element is used to monitor fluid flow or velocity through the implant based on the effect of the fluid on ultrasonic waves produced by the transducers.
  • the conformal array transducer comprises a plurality of elements that curve around the implant and are excited with an input signal provided by an implantable electronics circuit, producing ultrasonic waves that propagate into the fluid flowing within the graft or vessel. Transit time or Doppler measurements are made using an appropriate number of these transducer to determine either fluid flow or velocity.
  • Various implantable electronic circuits are provided that enable a selected transducer to be driven and to receive an ultrasonic signal or a pressure signal indicative of the status of fluid flow monitored by the transducer.
  • the implanted electronic circuit is connected to an implanted radio frequency (RF) coil.
  • An external coil that is connected to a power supply and monitoring console is coupled to the implanted RF coil to convey power and receive data signals from the transducer that are indicative of the parameter being monitored.
  • the monitoring means will be connected to data communication and/or storage means, to provide for online monitoring of the stored data.
  • Data can be stored in the implant or at a remote location. Means to access this information, and to download the data, are integrated so that the attending physician or nurse can monitor the patient long term, and provide corrections to the implant if necessary.
  • the storage means may be in the form of a silicon chip in the sensor or implant.
  • the monitoring means connected to the sensor(s) includes data storage means. This will typically be a computer, which may be connected to the internet or phone lines, so that data can be remotely accessed through phone lines (including beepers), other computers, or personal digital assistant (PDAs).
  • PDAs personal digital assistant
  • Actuators will typically consist of micromachined devices, or form a part of the implant. Alternatively, they can be in the form of reservoirs, switches or valves.
  • U.S. patent No. 5,536,963 describes a micromechanical structure or microactuator based upon the piezoelectric, pyroelectric, and electrostrictive properties of ferroelectric thin film ceramic materials such as PZT with a thickness between 0.1 and 10 micrometers, and method of manufacture thereof.
  • the thin film ceramic material is sandwiched between first and second electrodes and may contain an intermediate electrically insulating thin film.
  • This structure with electrodes is formed on a deformable or movable structure integral to a semiconductor or bulk ceramic substrate. Electrical connection is established between the upper and lower electrodes. A potential difference or voltage is established between the electrical interconnection points to produce a force, movement, or mechanical deformation.
  • the patent also discloses method for making such micromechanical structures or microactuators.
  • the implant may function as a conduit for fluids, solutes, electric charge, light, or other materials.
  • hollows within the implant walls, or the implant itself can be filled with a substance, such as a gel, that has a sensing functionality associated with it.
  • the substrate or enzyme can be immobilized in the interior of the implant, to create an integral needle/sensor.
  • Wave guides can be incorporated into the device to direct light to a specific location, or for dection, for example, using means such as a pH dye for color evaluation.
  • heat, electricity, light or other energy forms may be precisely transmitted to directly stimulate, damage, or heal a specific tissue or intermediary (e.g., tattoo remove for dark skinned persons), or diagnostic purposes, such as measurement of blood glucose based on IR spectra or by chromatographic means, measuring a color change in the presence of immobilized glucose oxidase in combination with an appropriate substrate.
  • the sensor detects one or more physical properties of its surrounding environment, and provides an output signal of the detected physical property to the control circuit.
  • the control circuit then sends data indicative of the detected physical property to a remote reader with an energy coupler or with a different energy coupler.
  • the control circuit can be encoded with identifying data before or after implantation. Such data may relate to the sensor, the patient into which the device is implanted or both.
  • the identifying data may also be a unique tag for accessing data stored in a remote data bank, such as a personal computer or a memory device in a remote reader. Hence, even after implantation of the implant with sensor(s), identifying data can be retrieved from control circuit in a non-invasive manner, as can data corresponding to sensed parameter values.
  • Ultrasonic and optical coupling can be used with a transponder for energizing and providing command signals to the transponder, and for transmitting identifying data, including unique tags, from the transponder to a remote reader.
  • a transponder can include more than one energy coupler, particularly where it is advantageous to energize the sensor with one form of energy, and transmit data using another. Where desirable, a third energy coupler can also be used to receive control commands from an external source using either the same or different forms of energy as those used for energizing the transponder and transmitting data therefrom.
  • Figure 1 is a flow diagram showing the interaction between the implant (I), sensor(s) (S), monitoring means (M), and actuating means (A), in the most typical embodiment.
  • Figure 2 is a flow diagram of a more complex embodiment, wherein the implant I is connected to a sensor S and transponder including an energy coupler and control circuit (referred to jointly as a biosensing transponder, as described for example, in U.S. Patent No. 5,833,603 ). This is in turn connected to a remote reader (or monitoring device) which sends a signal to the actuator to act upon the implant.
  • Figure 3 is a flow chart of the simplest embodiment, in which the system includes the implant, sensor and actuating means.
  • a sensor may communicate with a contiguous device, such as an actuator associated with an implanted device, an implanted device, or with a free-standing electronic communication device, or with a computer accessing the world wide web. In one embodiment of the invention, all these devices may communicate with each other, or in specific hierarchies.
  • the processing units of implants might be an integrated circuit with dedicated functions.
  • the sensing units might also be specialized integrated circuits, known colloquially as "biochips”.
  • Included with the implant may be a sensor that generates a signal in response to conditions detected by the sensor.
  • a sensor includes a memory means for storing information regarding the conditions, transmitting and receiving means, actuating means for carrying out a response by the implant to conditions sensed by the sensor, and a power source.
  • the sensor optionally includes an information processing means.
  • Various sensors may be employed to detect mechanical, sonic, electrical, chemical, temperature, and optical conditions, among others. Mechanical conditions sensed might include pressure, dimension, flow, and vibration.
  • the sensor generates a signal after sensing said conditions, which signal is sent to the transmitter, or which signal may be stored in the memory means.
  • the transmitter might transmit the signal by optical fiber, by wire, or wirelessly, using power from the power source.
  • the sensor might be programmed to transmit continuously, but more likely it would be programmed to transmit on a regular schedule to conserve energy, and transmit more frequently upon the sensing of a certain condition.
  • the power source might be a battery.
  • Optical transmission might be through optical fibers, while wired transmission might be though electrical transmission over an electrical conductor. Wireless transmission might take place through radio wave signals, or ultrasonically.
  • a standard communication protocol might be employed, such as a version of BLUETOOTH TM , which is promulgated by the Bluetooth Special Interest Group (which includes 3Com, IBM, Intel, Lucent, Microsoft and Nokia, among others).
  • the sensor may both transmit and receive information.
  • the person having the implant might wear on his person, or keep in close proximity, a repeater unit to strengthen the signal generated by the implanted sensor.
  • the sensor could include a smaller power source, and thus be more compact.
  • the repeating unit might also include a more sensitive receiver than the implant unit, and thus aid in transmissions back to the implanted sensor.
  • a person such as a physician, or the patient could monitor the transmissions from the sensor by means of a portable device, such as a personal digital assistant, portable computer, internet appliance, cellular telephone, two-way radio, web-enabled television, or watch communicator.
  • a person might monitor the transmissions from the sensor by using an ordinary telephone linked to a command menu, or which has speech to text and text to speech capabilities allowing the user to request the desired presentation of data.
  • the sensor could transmit to a receiving unit which would post the information sent by the implant sensor to a web page, accessible by the patient or the physician.
  • the web page would be accessible only by password, and the ability to issue commands to the device might be further password-protected.
  • a person monitoring the information sent by the implant sensor could transmit information back to the implant sensor.
  • Such information might be commands to be carried out through the actuator.
  • a sensor on a stent detected a mechanical narrowing of the internal passage
  • a physician might read that information from the web posting, and send a command back to the stent to the actuator to widen the passage.
  • the actuator might be a small mechanism in the stent that forces the stent to open more widely.
  • an optical sensor might detect the presence of unwanted cellular accumulation in the interior of the stent.
  • a physician might read that information, and send a command to the stent to the actuator to release a small amount of a protease to dissolve the accumulation.
  • the effector would be a reservoir containing protease, where a release mechanism on the reservoir could release a measured amount of protease.
  • the implant might be an implant in a deep abscess in a patient.
  • the implant might be an bandage, including expandable foam to promote healing.
  • the sensor might monitor local temperature to assess the presence or absence of infection. A monitoring, physician, observing a tell-tale warming, might direct the actuator to release a certain amount of an antibiotic solution.
  • a person such as a physician, might also communicate with the sensor directing it to issue an alert if certain conditions were sensed. For example, sensing of too great a narrowing of a vessel, or an erratic flow rate through a vessel, might be conditions for which a physician might direct the sensor to send an alert.
  • the sensor might be directed to download the information through the transmitter for permanent storage outside the sensor at various times. This would free up memory space in the sensor.
  • the information processing means may be programmed to have the actuator carry out certain actions in response to the sensing of certain conditions.
  • This programming might be effected through transmissions by a physician.
  • the physician might program the sensor, by remote transmissions, to carry out a certain schedule of release of an antibiotic.
  • the physician might program the sensor to release antibiotic at one schedule if a certain temperature were sensed, and another, more infrequent schedule, if another temperature were sensed.
  • the senor might be programmed to have the actuator release 0.5 ml of penicillin per ten hours if a temperature of 102 degrees Fahrenheit (33.9 degrees Centigrade) were sensed, but to reduce that schedule to 0.3 ml of penicillin per twenty hours when the temperature declined to 99.9 degrees Fahrenheit (37.8 degrees Centigrade).
  • the implant coupled to the sensor transmits information to a computer with a display means.
  • the computer might be any number of devices capable of receiving information, including personal digital assistants, pagers, telephones, internet appliances, watch communicators, and web-enabled televisions, as discussed above.
  • the communication might occur by some standard protocol, such as BLUETOOTH TM .
  • the user could transmit commands or inquiries directly back to the implant.
  • the implant coupled to the sensor again transmits to a computer.
  • the computer in this case might post the information to a web page on an internet site, probably password-protected.
  • a patient or physician could access this information by using a communications device to access the web site.
  • Commands could be sent directly to the implant from the accessing device, or via the web page and prompts on the web page ( Figure 4b only shows the direct command route).
  • the implant is coupled to a sensor, which transmits to a repeater unit worn by the patient, or in close proximity.
  • the repeater unit amplifies outgoing and incoming transmissions, and is in communication with an outside computer.
  • implant (10), in-body digital device (160), out-of-body digital device (170), and communication device (180) communicate with implant (10) and with the world wide web (150), preferably by posting to a web page (not shown). This might be referred to as a "nested loop”.
  • in-body digital device (160), out-of-body digital device (170), and communication device (180) all communicate with each other as well (not shown). These communications can encompass information received from the sensors (not shown) associated with the implant (10), as well as commands given to the actuator (not shown) of the implant (10).
  • any natural or synthetic, organic or inorganic molecule or mixture thereof can be delivered.
  • the implant is used to deliver drugs systemically to a patient in need thereof.
  • the construction and placement of the implant in a patient enables the localized release of drugs that may be too potent for systemic delivery.
  • drugs are organic or inorganic molecules, including proteins, nucleic acids, polysaccharides and synthetic organic molecules, having a bioactive effect, for example, anaesthetics, vaccines, chemotherapeutic agents, hormones, metabolites, sugars, immunomodulators, antioxidants, ion channel regulators, and antibiotics.
  • the drugs can be in the form of a single drug or drug mixtures and can include pharmaceutically acceptable carriers.
  • molecules are released in vitro in any system where the controlled release of a small (milligram to nanogram) amount of one or more molecules is required, for example, in the fields of analytic chemistry or medical diagnostics.
  • Molecules can be effective as pH buffering agents, diagnostic agents, and reagents.
  • U.S. Patent No. 5,797,898 to Santini, et al. describes implants for delivery of a wide variety of molecules. Implant or implants are miniaturized devices constructed using methods commonly applied to the manufacture of integrated circuits such as ultraviolet (UV) photolithography, reactive ion etching, and electron beam evaporation. The implants provide control over the rate the molecules are released as well as the time at which release begins. The time of release can be controlled passively or actively.
  • UV ultraviolet
  • the implant is formed of a material which is itself responsive to the environment, for example, to temperature or pH, which causes a change in the material, for example, an increase in pore size, thereby effecting release of the bioactive, prophylactic or diagnostic agent as needed.
  • a change in the material for example, an increase in pore size
  • an increase in pore size thereby effecting release of the bioactive, prophylactic or diagnostic agent as needed.
  • An example of such a situation is when the tissue around the implant becomes infected, thereby changing both the temperature and the pH.
  • Use of a temperature responsive material that increases porosity as the temperature increases can be used to deliver antibiotic only when, or in an increased amount when, infection is present.
  • micromachine actuators described herein can also be used to support or reinforce heart wall muscle in patients with congestive heart failure. These devices are implanted into the heart muscle, and contains both sensor and actuator means that synchronize expansion and contraction of devices secured to the heart wall muscle with the contraction and expansion of the normal, but impaired heart wall. By assisting the heart to function, patients that otherwise would die are provided with relief from the symptoms of the disease, including fluid on the lungs or fluid in the belly, liver and legs.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Vascular Medicine (AREA)
  • Optics & Photonics (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Prostheses (AREA)
  • Electrotherapy Devices (AREA)

Claims (32)

  1. System zum Überwachen der und Reagieren auf die Umgebung einer implantierten Vorrichtung (10), umfassend:
    einen oder mehrere Sensoren (40), der/die konfiguriert ist/sind, um Daten bezüglich Variablen, welche aus der Gruppe, bestehend aus elektrischen, magnetischen, mechanischen, Strömungs-, chemischen, biochemischen und thermischen Eigenschaften ausgewählt sind, in der Vorrichtung oder ihrer Umgebung bei einem Patienten zu überwachen,
    mindestens ein Bedienungselement (20), das konfiguriert ist, um eine Reaktion auf die überwachten Daten in der Vorrichtung zu implementieren; und
    Mittel zur Kommunikation an eine von einer Reihe von verschachtelten Informationsaustauschschleifen;
    wobei der eine oder die mehrere Sensoren (40) über das mindestens eine Bedienungselement (20) mit der Vorrichtung (10) derart direkt interagiert/interagieren, dass Daten, die von dem einen oder den mehreren Sensoren (40) auf das mindestens eine Bedienungselement (20) übermittelt wurden, in der Vorrichtung (10) eine Konfigurationsänderung bewirken;
    wobei der eine oder die mehreren Sensoren (40) und das mindestens eine Bedienungselement (20) konfiguriert ist/sind, um mindestens ein Gerät extern von der implantierbaren Vorrichtung zu steuern, und wobei einer oder mehrere Sensoren (40) in, auf oder Teil von der Vorrichtung (10) ist/sind, wobei das System dadurch gekennzeichnet ist, dass der eine oder die mehreren Sensoren Übermittlungs- und Empfangsmittel aufweist/aufweisen.
  2. System nach Anspruch 1, das ferner ein Datenspeicherungsmittel umfasst.
  3. System nach Anspruch 2, wobei das Datenspeicherungsmittel derart konfiguriert ist, dass es auf der Vorrichtung oder angrenzend an die Vorrichtung oder innerhalb des oder auf dem Körper des Patienten platzierbar ist.
  4. System nach Anspruch 1, das ferner ein Telemetriemittel umfasst.
  5. System nach Anspruch 4, wobei das Telemetriemittel eine analoge oder digitale elektronische Vorrichtung ist.
  6. System nach Anspruch 1, das einen externen Eingang umfasst, der durch Schlaufen angeschlossen ist, um von dem mindestens einen Bedienungselement eine Änderung in der Vorrichtung herbeizuführen.
  7. System nach Anspruch 1, das ferner ein Überwachungsmittel umfasst, das zur Positionierung extern vom Patienten konfiguriert ist.
  8. System nach Anspruch 1, wobei der Sensor konfiguriert ist, um Änderungen des pH-Werts, der Temperatur, der Ionenkonzentration oder der Analytkonzentration zu erfassen.
  9. System nach Anspruch 1, wobei der Sensor konfiguriert ist, um Änderungen der Temperatur, der Dimension, der Vibration, der Turbulenz, des Drucks, des Feuchtegehalts, des Magnetismus, des elektrischen Potentials und des elektrischen Stroms und der mechanischen oder Strömungseigenschaften zu erfassen.
  10. System nach Anspruch 9, wobei die mechanische Eigenschaft Spannung, Beanspruchung, Scherkraft, Strömung oder Druck ist.
  11. System nach Anspruch 1, wobei der Sensor konfiguriert ist, um eine Änderung der Platzierung der Vorrichtung zu erfassen.
  12. System nach Anspruch 1, wobei das Bedienungselement eine Mikromechanik ist, welche die Form oder Position des Implantats als Reaktion auf ein Signal von einem Sensor modifiziert.
  13. System nach Anspruch 1, wobei die Vorrichtung ein bioaktives, diagnostisches oder prophylaktisches Agens oder ein pH-Wert modifizierendes Agens, das in die Umgebung freigegeben werden kann, umfasst.
  14. System nach Anspruch 13, wobei das Agens mittels Diffusion freigegeben werden kann.
  15. System nach Anspruch 14, wobei die Diffusionsrate durch eine Änderung einer Variablen in der Umgebung erhöht werden kann.
  16. System nach Anspruch 15, wobei das Agens als Reaktion auf ein Signal von einem Sensor freigegeben werden kann.
  17. System nach Anspruch 13, wobei das Bedienungselement konfiguriert ist, um das Agens mechanisch durch Öffnungsmittel zum Überbringen oder Zurückbehalten des Agens freizugeben.
  18. System nach Anspruch 1, das ferner Übermittlungs- und Empfangsmittel für den einen oder die mehreren Sensoren umfasst.
  19. System nach Anspruch 1, das ferner Mittel zum fernen Zugreifen auf die Daten umfasst.
  20. System nach Anspruch 1, wobei der eine oder die mehreren Sensoren an Mittel zum Übermitteln oder Empfangen von Daten von einem Computer oder Telefonkommunikationsmittel angeschlossen sind.
  21. System nach Anspruch 1, wobei mindestens ein Sensor konfiguriert ist, um die Verschmutzung der Vorrichtung oder mindestens eines Sensors im Zeitablauf zu messen.
  22. System nach Anspruch 21, wobei mindestens ein Sensor konfiguriert ist, um die Proteinablagerung oder Bildung eines bakteriellen Films auf einem biliären Stent, die Erhöhung der Verkalkung eines Harnstents und die neointimale Verdickung eines arteriellen Stents, was in einer Erhöhung der Dicke, Masse und Scherkraft resultiert, zu messen.
  23. System nach Anspruch 1, wobei die Vorrichtung zur Implantierung in eine Arterie, Vene, Venenfistel, einen Gallengang, Harnleiter, Eileiter oder einen chirurgisch erzeugten künstlichen Raum geeignet ist.
  24. System nach Anspruch 1, wobei die Vorrichtung ein Stent ist.
  25. System nach Anspruch 1, wobei der eine oder die mehreren Sensoren in einen oder mehrere Chips auf der Vorrichtung inkorporiert ist/sind.
  26. System nach Anspruch 1, das ferner eine Stromquelle umfasst.
  27. System nach Anspruch 1, umfassend:
    (a) einen oder mehrere Sensoren zum Überwachen der allgemeinen Umgebung der implantierten Vorrichtung;
    (b) Überwachungsmittel; und
    (c) mindestens ein Bedienungselement;
    wobei der eine oder die mehreren Sensoren konfiguriert ist/sind, um Informationen an die Überwachungsmittel und einander zu kommunizieren und um Befehle an das Bedienungselement zu kommunizieren.
  28. System nach Anspruch 27, wobei der eine oder die mehreren Sensoren konfiguriert ist/sind, um Informationen an einen Computer, der die Informationen über das Internet an einen anderen Computer übermittelt, zu kommunizieren.
  29. System nach Anspruch 28, wobei die Übermittlung über das Internet an einen anderen Computer über das Entsenden an das World Wide Web geschieht.
  30. Implantierbare Vorrichtung (10), umfassend:
    einen oder mehrere Sensoren (40), der/die konfiguriert ist/sind, um mindestens einen Zustand zu überwachen;
    mindestens ein Bedienungselement (20), das konfiguriert ist, um eine Reaktion auf den überwachten Zustand in der Vorrichtung zu implementieren; und
    Mittel zur Kommunikation an eine von einer Reihe von verschachtelten Schleifen Informationsaustausch;
    wobei der eine oder die mehrere Sensoren (40) über das mindestens eine Bedienungselement (20) mit der Vorrichtung (10) direkt interagiert/interagieren; wobei
    der eine oder die mehreren Sensoren (40) und das mindestens eine Bedienungselement (20) konfiguriert ist/sind, um mindestens ein Gerät extern von der implantierbaren Vorrichtung zu steuern, und
    wobei der einer oder die mehreren Sensoren (40) in, auf oder Teil von der Vorrichtung (10) ist/sind, wobei die Vorrichtung dadurch gekennzeichnet ist, dass der eine oder die mehreren Sensoren Übermittlungs- und Empfangsmittel aufweist/aufweisen.
  31. Vorrichtung nach Anspruch 30, die zur Implantierung in eine Arterie, Vene, Venenfistel, einen Gallengang, Harnleiter, Eileiter oder einen chirurgisch erzeugten künstlichen Raum geeignet ist.
  32. Vorrichtung nach Anspruch 30, wobei der eine oder die mehreren Sensoren in einen oder mehrere Chips auf der Vorrichtung inkorporiert ist/sind.
EP00961948A 1999-09-17 2000-09-15 Medizinisches implantat zur fühlung, datenspeicherung und zur telemetrie Expired - Lifetime EP1215994B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07000766A EP1847217A2 (de) 1999-09-17 2000-09-15 Medinzinisches Implantat zur Fühlung, Datenspeicherung und Telemetrie von Signalen und zur Verabreichung einer Behandlung

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15463799P 1999-09-17 1999-09-17
US154637P 1999-09-17
PCT/US2000/025426 WO2001019239A1 (en) 1999-09-17 2000-09-15 Sensing, interrogating, storing, telemetering and responding medical implants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP07000766A Division EP1847217A2 (de) 1999-09-17 2000-09-15 Medinzinisches Implantat zur Fühlung, Datenspeicherung und Telemetrie von Signalen und zur Verabreichung einer Behandlung

Publications (2)

Publication Number Publication Date
EP1215994A1 EP1215994A1 (de) 2002-06-26
EP1215994B1 true EP1215994B1 (de) 2007-07-25

Family

ID=22552125

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00961948A Expired - Lifetime EP1215994B1 (de) 1999-09-17 2000-09-15 Medizinisches implantat zur fühlung, datenspeicherung und zur telemetrie

Country Status (7)

Country Link
EP (1) EP1215994B1 (de)
JP (1) JP2003509098A (de)
AT (1) ATE367763T1 (de)
AU (1) AU7383100A (de)
CA (1) CA2382846C (de)
DE (1) DE60035700T2 (de)
WO (1) WO2001019239A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8372139B2 (en) 2001-02-14 2013-02-12 Advanced Bio Prosthetic Surfaces, Ltd. In vivo sensor and method of making same
US7060030B2 (en) 2002-01-08 2006-06-13 Cardiac Pacemakers, Inc. Two-hop telemetry interface for medical device
US20040215067A1 (en) * 2003-04-24 2004-10-28 Stiger Mark L. Flow sensor device for endoscopic third ventriculostomy
DE102004006501A1 (de) 2004-02-10 2005-09-01 Charité-Universitätsmedizin Berlin Bauteil und Verfahren zum Zusammenbau einer Implantatanordnung
JP4680939B2 (ja) * 2004-02-10 2011-05-11 シネコー・エルエルシー 治療薬用脈管内送達システム
US8176922B2 (en) 2004-06-29 2012-05-15 Depuy Products, Inc. System and method for bidirectional communication with an implantable medical device using an implant component as an antenna
GB0424065D0 (en) * 2004-10-29 2004-12-01 Leuven K U Res & Dev Implantable strain controlling unit
US8001975B2 (en) 2004-12-29 2011-08-23 Depuy Products, Inc. Medical device communications network
US8309057B2 (en) * 2005-06-10 2012-11-13 The Invention Science Fund I, Llc Methods for elevating neurotrophic agents
US8998886B2 (en) 2005-12-13 2015-04-07 The Invention Science Fund I, Llc Remote control of osmotic pump device
US20070236213A1 (en) * 2006-03-30 2007-10-11 Paden Bradley E Telemetry method and apparatus using magnetically-driven mems resonant structure
US20080283066A1 (en) * 2007-05-17 2008-11-20 Cardiac Pacemakers, Inc. Delivery device for implantable sensors
US8080064B2 (en) 2007-06-29 2011-12-20 Depuy Products, Inc. Tibial tray assembly having a wireless communication device
US20090088726A1 (en) * 2007-09-28 2009-04-02 Microsoft Corporation Symbiotic biological systems as platforms for sensing, production, and intervention
CN102046085B (zh) * 2008-05-12 2013-12-25 心脏技术有限公司 光学传感器装置和使用光学传感器装置的方法
EP2470131B1 (de) * 2009-08-24 2014-11-12 New Phase Ltd Phasenwechselmaterialien
WO2014122467A1 (en) 2013-02-06 2014-08-14 Loxbridge Research Llp Systems and methods for early disease detection and real-time disease monitoring
KR102075090B1 (ko) * 2017-11-08 2020-02-07 아주대학교산학협력단 담도 폐쇄 모니터링 시스템 및 방법
US11083604B2 (en) 2019-01-18 2021-08-10 Lawrence Livermore National Security, Llc Preventing stent failure using adaptive shear responsive endovascular implant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001689A1 (en) * 1989-07-28 1991-02-21 Jacob Segalowitz Valvulotome catheter

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364385A (en) * 1981-03-13 1982-12-21 Lossef Steven V Insulin delivery device
US5056530A (en) * 1988-12-15 1991-10-15 University Of Cincinnati Method of measuring axial force in mammalian fibrous tissue and device
US5279607A (en) * 1991-05-30 1994-01-18 The State University Of New York Telemetry capsule and process
US5306294A (en) 1992-08-05 1994-04-26 Ultrasonic Sensing And Monitoring Systems, Inc. Stent construction of rolled configuration
US5544651A (en) * 1992-09-08 1996-08-13 Wilk; Peter J. Medical system and associated method for automatic treatment
US5769893A (en) * 1993-09-29 1998-06-23 Shah; Mrugesh K. Apparatus and method for promoting growth and repair of soft tissue
SE9403188D0 (sv) 1994-09-22 1994-09-22 Siemens Elema Ab Magnetfältsdetektor vid ett medicinskt implantat
US5833603A (en) * 1996-03-13 1998-11-10 Lipomatrix, Inc. Implantable biosensing transponder
JP3177677B2 (ja) 1996-05-14 2001-06-18 松下電器産業株式会社 超音波連続波ドプラ血流計
US5833623A (en) * 1996-05-14 1998-11-10 Pacesetter, Inc. System and method for facilitating rapid retrieval and evaluation of diagnostic data stored by an implantable medical device
US5938607A (en) * 1996-09-25 1999-08-17 Atl Ultrasound, Inc. Ultrasonic diagnostic imaging system with access to reference image library
EP0850654A1 (de) 1996-12-20 1998-07-01 Schneider (Usa) Inc. Katheter zur Feststellung einer implantierbaren Vorrichtung
JP4011631B2 (ja) 1997-01-03 2007-11-21 バイオセンス・インコーポレイテッド 圧力感応ステント
US6015387A (en) 1997-03-20 2000-01-18 Medivas, Llc Implantation devices for monitoring and regulating blood flow
JPH10273451A (ja) * 1997-03-28 1998-10-13 Japan Atom Energy Res Inst ｐＨ応答性機能を有するゲル
US6091980A (en) 1998-05-12 2000-07-18 Massachusetts Institute Of Technology Stent slip sensing system and method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001689A1 (en) * 1989-07-28 1991-02-21 Jacob Segalowitz Valvulotome catheter

Also Published As

Publication number Publication date
DE60035700D1 (de) 2007-09-06
WO2001019239A1 (en) 2001-03-22
CA2382846C (en) 2005-12-06
DE60035700T2 (de) 2008-04-30
JP2003509098A (ja) 2003-03-11
EP1215994A1 (de) 2002-06-26
CA2382846A1 (en) 2001-03-22
ATE367763T1 (de) 2007-08-15
AU7383100A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
US6802811B1 (en) Sensing, interrogating, storing, telemetering and responding medical implants
EP1215994B1 (de) Medizinisches implantat zur fühlung, datenspeicherung und zur telemetrie
TW552126B (en) Gateway platform for biological monitoring and delivery of therapeutic compounds
US6092530A (en) Remotely interrogated implant device with sensor for detecting accretion of biological matter
Veletic et al. Implants with sensing capabilities
EP1847217A2 (de) Medinzinisches Implantat zur Fühlung, Datenspeicherung und Telemetrie von Signalen und zur Verabreichung einer Behandlung
US20090177225A1 (en) Vascular closure device having sensor
US8926496B2 (en) Implantable device system
EP3764872B1 (de) Vorrichtung zur intravaskulären überwachung
US8231538B2 (en) Perivascular pressure sensor and sensing system
Honjol et al. Current view and prospect: Implantable pressure sensors for health and surgical care
Yu et al. Implantable Flexible Sensors for Health Monitoring
JP3894583B2 (ja) 生きた筋肉細胞を用いたセンサ
Abyzova et al. Beyond Tissue replacement: The Emerging role of smart implants in healthcare
Tang et al. Unconstrained Piezoelectric Vascular Electronics for Wireless Monitoring of Hemodynamics and Cardiovascular Health
Fricke et al. Real-time telemetric physiologic recordings of ventricle pressure-volume in an awake swine model with histopathological evaluation
Lin et al. The development of an in-vivo active pressure monitoring system
US20230027600A1 (en) System and method which provides wireless communication between bio-nano elements and macro/micro devices
Young et al. Wireless batteryless less-invasive blood pressure sensing microsystem for advanced biomedical application
Werner et al. Microsystems in Health Care Markets: recent Achievements and future trends
Aravamudhan MEMS for in vivo sensing
Khanna et al. Implantable Sensors
AU2012203630A1 (en) Gateway platform for biological monitoring and delivery of therapeutic compounds
Mahajan MEMS as In-Vivo Sensors and Actuators: Challenges and Opportunities

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020415

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20040217

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ENDOLUMINAL THERAPEUTICS, INC.

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SLEPIAN, MARVIN, J.

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60035700

Country of ref document: DE

Date of ref document: 20070906

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071105

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071226

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

EN Fr: translation not filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071026

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070930

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071025

26N No opposition filed

Effective date: 20080428

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080321

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070917

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070725

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070915

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070930

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20110316

Year of fee payment: 11

Ref country code: DE

Payment date: 20110331

Year of fee payment: 11

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20110915

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60035700

Country of ref document: DE

Effective date: 20120403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110915